What Brokers and TPAs Need To Know About Humira Biosimilars
Below is an excerpt from an article by AlignRx chief pharmacy officer Beckie Fenrick and Goodroot area vice president of business development Brian Shonat that was recently published in BenefitsPRO. Following decades of patent litigation and maneuvering, the first biosimilar to Humira is now available with many more to follow this year. Humira is a […]
What Brokers and TPAs Need To Know About Humira Biosimilars Read More »
